Gain Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Gain Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 61% to $55,180. Profit margin reached -40354%. Total operating expenses were $22,308,313.
Profit Margin
| 2018 | 20.60K | -1.10M | -5364.36% |
|---|---|---|---|
| 2019 | 41.30K | -2.19M | -5310.88% |
| 2020 | 28.88K | -3.57M | -12387.67% |
| 2021 | 164.99K | -13.89M | -8418.86% |
| 2022 | 140.10K | -17.59M | -12555.13% |
| 2023 | 55.18K | -22.26M | -40354.33% |
GANX Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 55.18K | 140.10K | 164.99K | 28.88K | 41.30K | 20.60K |
Cost of revenue | 80.38K | 64.16K | 7.16M | 2.25M | 0 | 0 |
Gross profit | -25.20K | 75.94K | -6.99M | -2.23M | 41.30K | 20.60K |
Operating exp. | ||||||
Research and development | 11.52M | 8.37M | 7.16M | 2.25M | 1.58M | 826.88K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.30M | 17.91M | 13.99M | 3.50M | 2.14M | 1.04M |
Operating income | -22.25M | -17.77M | -13.82M | -3.47M | -2.10M | -1.02M |
Other income (expenses), net | 64.88K | 279.28K | -60.42K | -92.84K | -86.22K | -14.96K |
Income before tax | -22.18M | -17.49M | -13.88M | -3.57M | -2.18M | -1.09M |
Income tax expense | 79.27K | 92.97K | 4.00K | 5.38K | 7.11K | 9.78K |
Net income | -22.26M | -17.59M | -13.89M | -3.57M | -2.19M | -1.10M |
Earnings per share | ||||||
Basic EPS | -1.71 | -1.48 | -1.37 | -0.3 | -0.18 | -0.19 |
Diluted EPS | -1.71 | -1.48 | -1.37 | -0.3 | -0.18 | -0.19 |
| Data source | Data source | Data source |